|By PR Newswire||
|August 5, 2014 10:12 AM EDT|
BURLINGTON, Mass., Aug. 5, 2014 /PRNewswire/ -- Decision Resources Group finds that the Canadian market for peripheral vascular (PV) devices will grow slightly through 2022 as procedural growth is largely offset by price declines. Although the Canadian market remains underpenetrated relative to other developed markets such as the United States or Europe, the landscape remains very difficult. As a result, manufacturers in this space will have to employ specific strategies to maintain growth in the Canadian market.
Other key findings from Decision Resources Group's coverage of the Canadian PV device market:
- Fixed annual hospital budgets: The public Canadian health care system is funded through annual fixed budget allocations for hospitals, resulting in a strong aversion to high upfront costs. Because endovascular treatments are more expensive than their surgical counterparts, Canadian facilities will be slow to adopt endovascular devices even though they have been proven to reduce hospital recovery times.
- Tender contracts and group purchasing: The extreme emphasis on cost also results in most hospitals purchasing through tender contracts or group purchasing organizations. This will create strong price competition among competitors, leading to declining prices.
- Conservative adopters: Because Canadian hospitals are public nonprofit entities, there is little need to compete for patients compared to more privatized health care markets. This has made Canadian physicians relatively conservative adopters of new technologies, which has further slowed the adoption of endovascular treatments and also continues to limit prices.
Comments from Decision Resources Group Team Lead Louise Murphy:
- "Drug-coated balloons and drug-eluting stents entered the Canadian market in 2013 and 2014, respectively. These products have been eagerly anticipated by Canadian physicians and will help to buoy the market overall. However, uptake will be slower than in other developed markets due to the highly cost-sensitive environment in Canada."
- "Manufacturers in the Canadian market should have a clear understanding of the underpenetration in Canada relative to other developed countries so that they can work with hospital purchasing departments to improve access to innovative technologies."
- Louise Murphy has written a Medtech 360 report on this subject entitled Canadian Markets for Peripheral Vascular Devices 2014.
- Louise Murphy has presented an analyst video on the subject of peripheral drug-coated balloons, which can be found here.
- Sivani Paskaradevan has written a blog post about cost-cutting in Canada, which can be found here.
About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.
For more information, contact:
Decision Resources Group
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
SOURCE Decision Resources Group
Join Impiger for their featured webinar: ‘Cloud Computing: A Roadmap to Modern Software Delivery’ on November 10, 2016, at 12:00 pm CST. Very few companies have not experienced some impact to their IT delivery due to the evolution of cloud computing. This webinar is not about deciding whether you should entertain moving some or all of your IT to the cloud, but rather, a detailed look under the hood to help IT professionals understand how cloud adoption has evolved and what trends will impact th...
Dec. 6, 2016 05:00 PM EST Reads: 2,577
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smar...
Dec. 6, 2016 04:45 PM EST Reads: 734
Dec. 6, 2016 04:04 PM EST Reads: 110
Dec. 6, 2016 04:00 PM EST Reads: 276
Dec. 6, 2016 03:31 PM EST Reads: 188
Dec. 6, 2016 03:15 PM EST Reads: 1,630
Dec. 6, 2016 03:15 PM EST Reads: 463
Dec. 6, 2016 02:30 PM EST Reads: 2,196
Dec. 6, 2016 02:30 PM EST Reads: 3,313
Dec. 6, 2016 02:15 PM EST Reads: 2,239
Dec. 6, 2016 02:15 PM EST Reads: 1,733
Dec. 6, 2016 02:00 PM EST Reads: 649
Dec. 6, 2016 02:00 PM EST Reads: 319
Bert Loomis was a visionary. This general session will highlight how Bert Loomis and people like him inspire us to build great things with small inventions. In their general session at 19th Cloud Expo, Harold Hannon, Architect at IBM Bluemix, and Michael O'Neill, Strategic Business Development at Nvidia, discussed the accelerating pace of AI development and how IBM Cloud and NVIDIA are partnering to bring AI capabilities to "every day," on-demand. They also reviewed two "free infrastructure" pr...
Dec. 6, 2016 01:45 PM EST Reads: 1,056
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
Dec. 6, 2016 01:30 PM EST Reads: 2,158